582303-10-4

Basic information

• Product Name: 3-Pyridinemethanol,2,6-dimethyl-(9CI)
• Synonyms: 3-Pyridinemethanol,2,6-dimethyl-(9CI);(2,6-dimethyl-pyridine-3-yl)methanol
• CAS NO: 582303-10-4
• Molecular Formula: C₈H₁₁NO
• Molecular Weight: 137.181
• Product Categories: PYRIDINE
• Mol File: 582303-10-4.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 245.4±35.0 °C(Predicted)
• Appearance: /
• Density: 1.063±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 13.73±0.10(Predicted)
• CAS DataBase Reference: 3-Pyridinemethanol,2,6-dimethyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridinemethanol,2,6-dimethyl-(9CI)(582303-10-4)
• EPA Substance Registry System: 3-Pyridinemethanol,2,6-dimethyl-(9CI)(582303-10-4)

Safety Data

• Hazardous Substances Data: 582303-10-4(Hazardous Substances Data)

Usage

General Description

3-Pyridinemethanol,2,6-dimethyl-(9CI) is a chemical compound with the molecular formula C9H13NO. It is a derivative of pyridine and has two methyl substituents at positions 2 and 6 of the pyridine ring. 3-Pyridinemethanol,2,6-dimethyl-(9CI) is commonly used as a building block for the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It has also been studied for its potential biological activities, including its antimicrobial and antifungal properties. 3-Pyridinemethanol,2,6-dimethyl-(9CI) may also be used as a solvent, reagent, or intermediate in various chemical processes. Overall, this compound has diverse applications and is an important component in the field of organic chemistry.

Upstream product

• 1721-13-7 ethyl 2,6-dimethylnicotinate 
• 70271-80-6 ethyl 4-chloro-2,6-dimethylnicotinate 

Downstream Products

• 650141-20-1 2,6-dimethylpyridine-3-carboxaldehyde 
• 118420-52-3 (E)-N-[4-(4-Benzhydryl-piperazin-1-yl)-butyl]-3-(2,6-dimethyl-pyridin-3-yl)-acrylamide 
• 1462-84-6 2,3,6-trimethylpyridine 
• 672325-49-4 (2,6-dimethylpyridin-3-yl)methanamine 

Relevant articles and documents

SUBSTITUTED PYRIDIZINONE DERIVATIVES AS PDE10 INHIBITORS

The present invention is directed to substituted pyridizinone compounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Alpha-substituted arylalkyl phosphonate derivatives

The present invention relates to novel α-substituted arylalkylphosphonate derivatives and their uses for lowering plasma levels of apo (a), Lp(a), apo B, apo B associated lipoproteins (low density lipoproteins and very low density lipoproteins) and for lo